TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Rejection; Transplant, KidneyRejection; Transplant, Pancreas
Interventions
DRUG

Methylprednisolone

IV Methylprednisolone

DRUG

Prednisone

Oral prednisone augmentation

Trial Locations (25)

1023

Auckland City Hospital, Grafton

2014

Queensland Children's Hospital, South Brisbane

2031

Prince of Wales Hospital, Randwick

2145

The Sydney Children's Hospital Network, Westmead

Westmead Hospital, Westmead

2305

John Hunter Hospital, Lambton

3168

Monash Medical Centre, Clayton

4102

Princess Alexandra Hospital, Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

6000

Royal Perth Hospital, Perth

6009

Royal Perth Children's hospital, Nedlands

Sir Charles Gairdner Hospital, Nedlands

T2N 1N4

University of Calgary, Calgary

T6G 2R3

University of Alberta, Edmonton

R3A 1R9

Transplant Manitoba, adult, Winnipeg

Transplant Manitoba, pediatric, Winnipeg

B3H 4R2

Dalhousie University, Halifax

N6A 3K7

Western University, London

M5B 1W8

University of Toronto - St Michael Hospital, Toronto

M5G 1E8

University of Toronto - Hospital for Sick Kids, Toronto

M5S 1A1

University of Toronto, Toronto

H3A 0G4

McGill University, Montreal

H3T 1J4

University of Montreal, Montreal

G1V 0B4

University of Laval, Québec

S7N 5A2

University of Saskatchewan, Saskatoon

All Listed Sponsors
collaborator

University of Manitoba

OTHER

lead

University of Sydney

OTHER